台灣臨床試驗主持人資料庫|TPIDB

2015-08-01 - 2017-12-31

Phase III

A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of dupilumab in patients with persistent asthma

Condition/Disease

persistent asthma
Test Drug

dupilumab

Participate Sites
12Sites

Terminated10Sites

李岡遠

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Cardiovascular Diseases

鍾啟禮

Taipei WanFang Hospital (Managed by Taipei Medical Univeristy)

Division of Cardiovascular Diseases

2018-12-27 - 2021-03-22

Phase I

A Multicenter, Open-Label Phase 1 Study of DS-1205c in Combination With Osimertinib in Subjects With Metastatic or Unresectable EGFR-Mutant Non-Small Cell Lung Cancer

Condition/Disease

Non-small Cell Lung Cancer
Test Drug

DS-1205c

Participate Sites
9Sites

Terminated7Sites

夏和雄

Taipei Medical University Hospital

李岡遠

Taipei WanFang Hospital (Managed by Taipei Medical Univeristy)

未分科

2017-09-01 - 2019-10-31

Phase III

A Multicenter, Randomized, Double-blind, Parallel-group, Clinical Study of S-649266 Compared With Meropenem for the Treatment of Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia, or Healthcare-associated Bacterial Pneumonia Caused by Gram-negative Pathogens

Condition/Disease

Hospital-acquired Bacterial Pneumonia, Ventilator-associatedBacterial Pneumonia, or Healthcare-associated BacterialPneumonia Caused by Gram-negative Pathogens
Test Drug

S-649266

Participate Sites
4Sites

Terminated4Sites

李岡遠

Taipei Medical University-Shuang Ho Hospital,Ministry of Health and Welfare

Division of Thoracic Medicine

李文生

Taipei WanFang Hospital (Managed by Taipei Medical Univeristy)

Division of Infectious Disease

2017-02-10 - 2025-12-31

Phase III

A Global, Randomized, Phase 3, Open-Label Study of REGN2810 (Anti PD 1 Antibody) versus Platinum Based Chemotherapy in First Line Treatment of Patients with Advanced or Metastatic PD L1 + Non-Small Cell Lung Cancer

Condition/Disease

NSCLC
Test Drug

REGN2810

Participate Sites
17Sites

Recruiting13Sites

Terminated2Sites

夏德椿

China Medical University Hospital-Taipei

未分科

張家崙

Taipei WanFang Hospital (Managed by Taipei Medical Univeristy)

Division of Hematology & Oncology

2017-07-01 - 2018-09-30

Phase II

A Phase 2, Double-blind, Randomized Controlled Study to Evaluate Immunogenicity and Safety of Intranasal Trivalent Influenza Virus Vaccine in Healthy Adult Volunteers

Condition/Disease

Influenza Virus Vaccine
Test Drug

AD07030

Participate Sites
5Sites

Terminated5Sites

劉明哲

Taipei Medical University Hospital

Division of Urology

李文生

Taipei WanFang Hospital (Managed by Taipei Medical Univeristy)

Division of Infectious Disease

Search Result

List